Evaxion - Net Change in Long-Term Investments 2020-2025 | EVAX
Evaxion - net change in long-term investments from 2020 to 2025. Net change in long-term investments can be defined as the net cash flows from the sale and purchase of investments with maturities greater than one year.
| Evaxion - Annual Net Change in Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.004B | $0.003B |
| Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.151B | 48.75 |
| Hims & Hers Health (HIMS) | United States | $11.939B | 124.05 |
| Tempus AI (TEM) | United States | $9.210B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.513B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.137B | 64.64 |
| Privia Health (PRVA) | United States | $2.813B | 192.25 |
| Enovis (ENOV) | United States | $1.861B | 10.37 |
| Clover Health Investments (CLOV) | United States | $1.593B | 0.00 |
| Schrodinger (SDGR) | United States | $1.579B | 0.00 |
| Phreesia (PHR) | United States | $1.385B | 0.00 |
| Omnicell (OMCL) | United States | $1.376B | 24.27 |
| Azenta (AZTA) | United States | $1.241B | 57.66 |
| 10x Genomics (TXG) | United States | $1.091B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.626B | 0.00 |
| Talkspace (TALK) | United States | $0.495B | 148.00 |
| Veradigm (MDRX) | United States | $0.460B | 0.00 |
| Claritev (CTEV) | United States | $0.438B | 0.00 |
| Standard BioTools (LAB) | United States | $0.414B | 0.00 |
| TruBridge (TBRG) | United States | $0.358B | 793.33 |
| Outset Medical (OM) | United States | $0.346B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.256B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.132B | 0.00 |
| Pulmonx (LUNG) | United States | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.100B | 0.00 |
| CareCloud (CCLD) | United States | $0.087B | 3.31 |
| 111 (YI) | China | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |